Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 2”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Not applicableLooking for participantsNCT06618807
What this trial is testing

Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Unity Health Toronto 60
Not applicableStudy completedNCT03371706
What this trial is testing

Communication Bridge 2

Who this might be right for
Primary Progressive Aphasia
University of Chicago 190
Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Not applicableStudy completedNCT01329536
What this trial is testing

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseAgitation
Avera McKennan Hospital & University Health Center 50
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Not applicableUnknownNCT04027712
What this trial is testing

Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD

Who this might be right for
DiabetesClopidogrel ResistanceAmyloid+1 more
University of Athens 120
Testing effectiveness (Phase 2)Study completedNCT02907567
What this trial is testing

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cognition Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Not applicableUnknownNCT06072014
What this trial is testing

ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)

Who this might be right for
Dementia Alzheimers
Augmented eXperience E-health Laboratory 30
Testing effectiveness (Phase 2)Ended earlyNCT03702816
What this trial is testing

The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)

Who this might be right for
Alzheimer DiseaseParkinson DiseaseInflammation
Aaron Ritter, MD 24
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Ended earlyNCT02565511
What this trial is testing

CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Novartis Pharmaceuticals 480
Early research (Phase 1)Study completedNCT01254448
What this trial is testing

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Targacept Inc. 38
Testing effectiveness (Phase 2)Ended earlyNCT02406027
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 90
Testing effectiveness (Phase 2)Study completedNCT04538066
What this trial is testing

Bryostatin Treatment of Moderately Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Neurotrope Bioscience, Inc. 122
Large-scale testing (Phase 3)Ended earlyNCT02916056
What this trial is testing

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Who this might be right for
Alzheimer's Disease
vTv Therapeutics 297
Not applicableStudy completedNCT05847153
What this trial is testing

MASC: Reducing Stress for Caregivers

Who this might be right for
Alzheimer Disease and Related DementiasDementia Alzheimers
Massachusetts General Hospital 13
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT05189210
What this trial is testing

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Mild to Moderate Alzheimer's Disease
GemVax & Kael 199
Early research (Phase 1)Study completedNCT02502253
What this trial is testing

BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Johns Hopkins University 14
Load More Results